FDA approves Ultragenyx's gene therapy Genglycos for glycogen storage disorder

Ultragenyx has secured its first approved gene therapy, with the FDA clearing its asset for an ultra-rare disease that can cause life-threatening blood sugar crashes. The FDA on Wednesday granted accelerated ...